Share this article Share this article ResearchAndMarkets.com's offering. The global volume of IVD procedures is forecast to increase 7.9% annually to 111.3 billion in 2025. In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The same timeframe will see worldwide sales of IVD products expanding 5.4% per year to $95 billion. Blood glucose monitoring activities will account for approximately 76% of testing volume and about $20 billion of product sales. Excluding blood glucose tests, global IVD procedural volume is forecast to rise 4.0% annually to 28.8 billion in 2025, with product sales increasing 5.3% annually to almost $76.5 billion.